These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 16007339

  • 1. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, Lichtler AC, Clark SH, Gronowicz GA.
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [Abstract] [Full Text] [Related]

  • 2. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
    Zhang W, Pantschenko AG, McCarthy MB, Gronowicz G.
    Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
    Harrison JR, Huang YF, Wilson KA, Kelly PL, Adams DJ, Gronowicz GA, Clark SH.
    J Biol Chem; 2005 Mar 04; 280(9):8117-24. PubMed ID: 15598659
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor II induces apoptosis in osteoblasts.
    Gronowicz GA, McCarthy MB, Zhang H, Zhang W.
    Bone; 2004 Sep 04; 35(3):621-8. PubMed ID: 15336597
    [Abstract] [Full Text] [Related]

  • 7. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
    Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE.
    Bone; 2010 Sep 04; 47(3):573-82. PubMed ID: 20541046
    [Abstract] [Full Text] [Related]

  • 8. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.
    Phytomedicine; 2013 Nov 15; 20(14):1256-66. PubMed ID: 23928508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M.
    APMIS Suppl; 1997 Nov 15; 71():1-30. PubMed ID: 9357492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
    Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC.
    J Bone Miner Res; 2004 May 15; 19(5):811-22. PubMed ID: 15068505
    [Abstract] [Full Text] [Related]

  • 14. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
    Dela Cruz A, Mattocks M, Sugamori KS, Grynpas MD, Mitchell J.
    Bone; 2014 Feb 15; 59():211-22. PubMed ID: 24308950
    [Abstract] [Full Text] [Related]

  • 15. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L, Quarles LD, Spurney RF.
    J Bone Miner Res; 2004 Oct 15; 19(10):1661-70. PubMed ID: 15355561
    [Abstract] [Full Text] [Related]

  • 16. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone.
    Sher LB, Woitge HW, Adams DJ, Gronowicz GA, Krozowski Z, Harrison JR, Kream BE.
    Endocrinology; 2004 Feb 15; 145(2):922-9. PubMed ID: 14617568
    [Abstract] [Full Text] [Related]

  • 17. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
    Wiren KM, Toombs AR, Semirale AA, Zhang X.
    Bone; 2006 May 15; 38(5):637-51. PubMed ID: 16413235
    [Abstract] [Full Text] [Related]

  • 18. Osteoblast menin regulates bone mass in vivo.
    Kanazawa I, Canaff L, Abi Rafeh J, Angrula A, Li J, Riddle RC, Boraschi-Diaz I, Komarova SV, Clemens TL, Murshed M, Hendy GN.
    J Biol Chem; 2015 Feb 13; 290(7):3910-24. PubMed ID: 25538250
    [Abstract] [Full Text] [Related]

  • 19. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
    Frara N, Abdelmagid SM, Sondag GR, Moussa FM, Yingling VR, Owen TA, Popoff SN, Barbe MF, Safadi FF.
    J Cell Physiol; 2016 Jan 13; 231(1):72-83. PubMed ID: 25899717
    [Abstract] [Full Text] [Related]

  • 20. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L, Liu S, Quarles LD, Spurney RF.
    Am J Physiol Endocrinol Metab; 2005 Apr 13; 288(4):E826-34. PubMed ID: 15585587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.